nodes	percent_of_prediction	percent_of_DWPC	metapath
Posaconazole—ABCB1—Sorafenib—liver cancer	0.117	0.389	CbGbCtD
Posaconazole—ABCB1—Doxorubicin—liver cancer	0.0707	0.236	CbGbCtD
Posaconazole—CYP3A4—Sorafenib—liver cancer	0.0698	0.233	CbGbCtD
Posaconazole—CYP3A4—Doxorubicin—liver cancer	0.0424	0.141	CbGbCtD
Posaconazole—Itraconazole—CYP2E1—liver cancer	0.00453	0.388	CrCbGaD
Posaconazole—Itraconazole—CYP1A1—liver cancer	0.00447	0.383	CrCbGaD
Posaconazole—Ketoconazole—CYP1A1—liver cancer	0.00268	0.229	CrCbGaD
Posaconazole—CYP3A4—Felbamate Metabolism—CYP2E1—liver cancer	0.00115	0.0807	CbGpPWpGaD
Posaconazole—CYP3A4—Liver X Receptor Pathway—SCD—liver cancer	0.000691	0.0485	CbGpPWpGaD
Posaconazole—ABCB1—Drug Induction of Bile Acid Pathway—NR1H4—liver cancer	0.000618	0.0434	CbGpPWpGaD
Posaconazole—ABCB1—Drug Induction of Bile Acid Pathway—NR1I3—liver cancer	0.000608	0.0427	CbGpPWpGaD
Posaconazole—Nasopharyngitis—Epirubicin—liver cancer	0.000606	0.000899	CcSEcCtD
Posaconazole—Face oedema—Doxorubicin—liver cancer	0.000606	0.000898	CcSEcCtD
Posaconazole—Gastritis—Epirubicin—liver cancer	0.0006	0.00089	CcSEcCtD
Posaconazole—Alanine aminotransferase increased—Epirubicin—liver cancer	0.000598	0.000887	CcSEcCtD
Posaconazole—Muscular weakness—Epirubicin—liver cancer	0.000598	0.000887	CcSEcCtD
Posaconazole—Dizziness—Sorafenib—liver cancer	0.000596	0.000884	CcSEcCtD
Posaconazole—Mood swings—Doxorubicin—liver cancer	0.000594	0.000881	CcSEcCtD
Posaconazole—Abdominal distension—Epirubicin—liver cancer	0.00059	0.000875	CcSEcCtD
Posaconazole—Ataxia—Doxorubicin—liver cancer	0.00059	0.000875	CcSEcCtD
Posaconazole—Blood creatinine increased—Doxorubicin—liver cancer	0.000588	0.000871	CcSEcCtD
Posaconazole—Dysphagia—Epirubicin—liver cancer	0.000586	0.000869	CcSEcCtD
Posaconazole—Dehydration—Doxorubicin—liver cancer	0.000584	0.000865	CcSEcCtD
Posaconazole—Eosinophilia—Epirubicin—liver cancer	0.00058	0.00086	CcSEcCtD
Posaconazole—Liver function test abnormal—Doxorubicin—liver cancer	0.000579	0.000859	CcSEcCtD
Posaconazole—Dry skin—Doxorubicin—liver cancer	0.000575	0.000853	CcSEcCtD
Posaconazole—Pancreatitis—Epirubicin—liver cancer	0.000575	0.000852	CcSEcCtD
Posaconazole—Vomiting—Sorafenib—liver cancer	0.000573	0.00085	CcSEcCtD
Posaconazole—Abdominal pain upper—Doxorubicin—liver cancer	0.000573	0.00085	CcSEcCtD
Posaconazole—Orthostatic hypotension—Doxorubicin—liver cancer	0.000573	0.00085	CcSEcCtD
Posaconazole—Hypokalaemia—Doxorubicin—liver cancer	0.000571	0.000847	CcSEcCtD
Posaconazole—Rash—Sorafenib—liver cancer	0.000569	0.000843	CcSEcCtD
Posaconazole—Dermatitis—Sorafenib—liver cancer	0.000568	0.000842	CcSEcCtD
Posaconazole—Breast disorder—Doxorubicin—liver cancer	0.000567	0.000841	CcSEcCtD
Posaconazole—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.000565	0.000838	CcSEcCtD
Posaconazole—Headache—Sorafenib—liver cancer	0.000565	0.000838	CcSEcCtD
Posaconazole—Nasopharyngitis—Doxorubicin—liver cancer	0.000561	0.000832	CcSEcCtD
Posaconazole—Pancytopenia—Epirubicin—liver cancer	0.000557	0.000825	CcSEcCtD
Posaconazole—Gastritis—Doxorubicin—liver cancer	0.000555	0.000823	CcSEcCtD
Posaconazole—Muscular weakness—Doxorubicin—liver cancer	0.000553	0.00082	CcSEcCtD
Posaconazole—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.000553	0.00082	CcSEcCtD
Posaconazole—Dysuria—Epirubicin—liver cancer	0.000548	0.000813	CcSEcCtD
Posaconazole—Neutropenia—Epirubicin—liver cancer	0.000548	0.000813	CcSEcCtD
Posaconazole—Abdominal distension—Doxorubicin—liver cancer	0.000546	0.000809	CcSEcCtD
Posaconazole—Upper respiratory tract infection—Epirubicin—liver cancer	0.000545	0.000808	CcSEcCtD
Posaconazole—Dysphagia—Doxorubicin—liver cancer	0.000542	0.000804	CcSEcCtD
Posaconazole—Pollakiuria—Epirubicin—liver cancer	0.000542	0.000803	CcSEcCtD
Posaconazole—Eosinophilia—Doxorubicin—liver cancer	0.000537	0.000796	CcSEcCtD
Posaconazole—Nausea—Sorafenib—liver cancer	0.000536	0.000794	CcSEcCtD
Posaconazole—Weight increased—Epirubicin—liver cancer	0.000533	0.000791	CcSEcCtD
Posaconazole—Pancreatitis—Doxorubicin—liver cancer	0.000532	0.000788	CcSEcCtD
Posaconazole—Weight decreased—Epirubicin—liver cancer	0.00053	0.000786	CcSEcCtD
Posaconazole—Hyperglycaemia—Epirubicin—liver cancer	0.000529	0.000784	CcSEcCtD
Posaconazole—Pneumonia—Epirubicin—liver cancer	0.000526	0.000779	CcSEcCtD
Posaconazole—Infestation—Epirubicin—liver cancer	0.000523	0.000775	CcSEcCtD
Posaconazole—Infestation NOS—Epirubicin—liver cancer	0.000523	0.000775	CcSEcCtD
Posaconazole—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.000518	0.000768	CcSEcCtD
Posaconazole—Pancytopenia—Doxorubicin—liver cancer	0.000515	0.000764	CcSEcCtD
Posaconazole—Renal failure—Epirubicin—liver cancer	0.000514	0.000762	CcSEcCtD
Posaconazole—Neuropathy peripheral—Epirubicin—liver cancer	0.000512	0.000759	CcSEcCtD
Posaconazole—Stomatitis—Epirubicin—liver cancer	0.000509	0.000755	CcSEcCtD
Posaconazole—Jaundice—Epirubicin—liver cancer	0.000509	0.000755	CcSEcCtD
Posaconazole—Conjunctivitis—Epirubicin—liver cancer	0.000508	0.000753	CcSEcCtD
Posaconazole—Urinary tract infection—Epirubicin—liver cancer	0.000508	0.000753	CcSEcCtD
Posaconazole—Dysuria—Doxorubicin—liver cancer	0.000507	0.000752	CcSEcCtD
Posaconazole—Neutropenia—Doxorubicin—liver cancer	0.000507	0.000752	CcSEcCtD
Posaconazole—Upper respiratory tract infection—Doxorubicin—liver cancer	0.000504	0.000747	CcSEcCtD
Posaconazole—Pollakiuria—Doxorubicin—liver cancer	0.000501	0.000743	CcSEcCtD
Posaconazole—Haematuria—Epirubicin—liver cancer	0.000498	0.000739	CcSEcCtD
Posaconazole—Hepatobiliary disease—Epirubicin—liver cancer	0.000494	0.000733	CcSEcCtD
Posaconazole—Weight increased—Doxorubicin—liver cancer	0.000494	0.000732	CcSEcCtD
Posaconazole—Epistaxis—Epirubicin—liver cancer	0.000493	0.000731	CcSEcCtD
Posaconazole—Weight decreased—Doxorubicin—liver cancer	0.000491	0.000727	CcSEcCtD
Posaconazole—Sinusitis—Epirubicin—liver cancer	0.00049	0.000727	CcSEcCtD
Posaconazole—Hyperglycaemia—Doxorubicin—liver cancer	0.000489	0.000725	CcSEcCtD
Posaconazole—Agranulocytosis—Epirubicin—liver cancer	0.000488	0.000723	CcSEcCtD
Posaconazole—Pneumonia—Doxorubicin—liver cancer	0.000486	0.000721	CcSEcCtD
Posaconazole—Infestation NOS—Doxorubicin—liver cancer	0.000484	0.000717	CcSEcCtD
Posaconazole—Infestation—Doxorubicin—liver cancer	0.000484	0.000717	CcSEcCtD
Posaconazole—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.000479	0.000711	CcSEcCtD
Posaconazole—Bradycardia—Epirubicin—liver cancer	0.000478	0.000708	CcSEcCtD
Posaconazole—Renal failure—Doxorubicin—liver cancer	0.000475	0.000705	CcSEcCtD
Posaconazole—Neuropathy peripheral—Doxorubicin—liver cancer	0.000474	0.000703	CcSEcCtD
Posaconazole—Haemoglobin—Epirubicin—liver cancer	0.000472	0.000699	CcSEcCtD
Posaconazole—Jaundice—Doxorubicin—liver cancer	0.000471	0.000699	CcSEcCtD
Posaconazole—Stomatitis—Doxorubicin—liver cancer	0.000471	0.000699	CcSEcCtD
Posaconazole—Rhinitis—Epirubicin—liver cancer	0.00047	0.000697	CcSEcCtD
Posaconazole—Conjunctivitis—Doxorubicin—liver cancer	0.00047	0.000697	CcSEcCtD
Posaconazole—Urinary tract infection—Doxorubicin—liver cancer	0.00047	0.000697	CcSEcCtD
Posaconazole—Haemorrhage—Epirubicin—liver cancer	0.000469	0.000696	CcSEcCtD
Posaconazole—Hepatitis—Epirubicin—liver cancer	0.000469	0.000696	CcSEcCtD
Posaconazole—Hypoaesthesia—Epirubicin—liver cancer	0.000467	0.000692	CcSEcCtD
Posaconazole—Pharyngitis—Epirubicin—liver cancer	0.000466	0.00069	CcSEcCtD
Posaconazole—Urinary tract disorder—Epirubicin—liver cancer	0.000463	0.000687	CcSEcCtD
Posaconazole—Oedema peripheral—Epirubicin—liver cancer	0.000462	0.000685	CcSEcCtD
Posaconazole—Haematuria—Doxorubicin—liver cancer	0.000461	0.000684	CcSEcCtD
Posaconazole—Connective tissue disorder—Epirubicin—liver cancer	0.000461	0.000683	CcSEcCtD
Posaconazole—Urethral disorder—Epirubicin—liver cancer	0.00046	0.000682	CcSEcCtD
Posaconazole—Hepatobiliary disease—Doxorubicin—liver cancer	0.000457	0.000678	CcSEcCtD
Posaconazole—Epistaxis—Doxorubicin—liver cancer	0.000456	0.000676	CcSEcCtD
Posaconazole—Sinusitis—Doxorubicin—liver cancer	0.000454	0.000673	CcSEcCtD
Posaconazole—Agranulocytosis—Doxorubicin—liver cancer	0.000451	0.000669	CcSEcCtD
Posaconazole—Erythema multiforme—Epirubicin—liver cancer	0.000444	0.000658	CcSEcCtD
Posaconazole—Bradycardia—Doxorubicin—liver cancer	0.000442	0.000655	CcSEcCtD
Posaconazole—Eye disorder—Epirubicin—liver cancer	0.000438	0.00065	CcSEcCtD
Posaconazole—Tinnitus—Epirubicin—liver cancer	0.000437	0.000648	CcSEcCtD
Posaconazole—Haemoglobin—Doxorubicin—liver cancer	0.000436	0.000647	CcSEcCtD
Posaconazole—Cardiac disorder—Epirubicin—liver cancer	0.000435	0.000645	CcSEcCtD
Posaconazole—Flushing—Epirubicin—liver cancer	0.000435	0.000645	CcSEcCtD
Posaconazole—Rhinitis—Doxorubicin—liver cancer	0.000435	0.000645	CcSEcCtD
Posaconazole—Haemorrhage—Doxorubicin—liver cancer	0.000434	0.000644	CcSEcCtD
Posaconazole—Hepatitis—Doxorubicin—liver cancer	0.000434	0.000644	CcSEcCtD
Posaconazole—Hypoaesthesia—Doxorubicin—liver cancer	0.000432	0.00064	CcSEcCtD
Posaconazole—Pharyngitis—Doxorubicin—liver cancer	0.000431	0.000639	CcSEcCtD
Posaconazole—Urinary tract disorder—Doxorubicin—liver cancer	0.000429	0.000636	CcSEcCtD
Posaconazole—Oedema peripheral—Doxorubicin—liver cancer	0.000428	0.000634	CcSEcCtD
Posaconazole—Connective tissue disorder—Doxorubicin—liver cancer	0.000427	0.000632	CcSEcCtD
Posaconazole—Angiopathy—Epirubicin—liver cancer	0.000426	0.000631	CcSEcCtD
Posaconazole—Urethral disorder—Doxorubicin—liver cancer	0.000426	0.000631	CcSEcCtD
Posaconazole—Immune system disorder—Epirubicin—liver cancer	0.000424	0.000628	CcSEcCtD
Posaconazole—Mediastinal disorder—Epirubicin—liver cancer	0.000423	0.000627	CcSEcCtD
Posaconazole—Chills—Epirubicin—liver cancer	0.000421	0.000624	CcSEcCtD
Posaconazole—Arrhythmia—Epirubicin—liver cancer	0.000419	0.000621	CcSEcCtD
Posaconazole—Alopecia—Epirubicin—liver cancer	0.000415	0.000615	CcSEcCtD
Posaconazole—Mental disorder—Epirubicin—liver cancer	0.000411	0.000609	CcSEcCtD
Posaconazole—Erythema multiforme—Doxorubicin—liver cancer	0.00041	0.000608	CcSEcCtD
Posaconazole—Erythema—Epirubicin—liver cancer	0.000408	0.000605	CcSEcCtD
Posaconazole—Malnutrition—Epirubicin—liver cancer	0.000408	0.000605	CcSEcCtD
Posaconazole—Eye disorder—Doxorubicin—liver cancer	0.000406	0.000601	CcSEcCtD
Posaconazole—Tinnitus—Doxorubicin—liver cancer	0.000405	0.0006	CcSEcCtD
Posaconazole—Cardiac disorder—Doxorubicin—liver cancer	0.000403	0.000597	CcSEcCtD
Posaconazole—Flushing—Doxorubicin—liver cancer	0.000403	0.000597	CcSEcCtD
Posaconazole—Flatulence—Epirubicin—liver cancer	0.000402	0.000597	CcSEcCtD
Posaconazole—Dysgeusia—Epirubicin—liver cancer	0.0004	0.000593	CcSEcCtD
Posaconazole—Back pain—Epirubicin—liver cancer	0.000395	0.000586	CcSEcCtD
Posaconazole—Angiopathy—Doxorubicin—liver cancer	0.000394	0.000584	CcSEcCtD
Posaconazole—Muscle spasms—Epirubicin—liver cancer	0.000393	0.000582	CcSEcCtD
Posaconazole—Immune system disorder—Doxorubicin—liver cancer	0.000392	0.000581	CcSEcCtD
Posaconazole—Mediastinal disorder—Doxorubicin—liver cancer	0.000391	0.00058	CcSEcCtD
Posaconazole—Chills—Doxorubicin—liver cancer	0.00039	0.000577	CcSEcCtD
Posaconazole—Arrhythmia—Doxorubicin—liver cancer	0.000388	0.000575	CcSEcCtD
Posaconazole—Vision blurred—Epirubicin—liver cancer	0.000385	0.000571	CcSEcCtD
Posaconazole—Alopecia—Doxorubicin—liver cancer	0.000384	0.000569	CcSEcCtD
Posaconazole—CYP3A4—Drug Induction of Bile Acid Pathway—NR1H4—liver cancer	0.000381	0.0267	CbGpPWpGaD
Posaconazole—Mental disorder—Doxorubicin—liver cancer	0.00038	0.000564	CcSEcCtD
Posaconazole—Ill-defined disorder—Epirubicin—liver cancer	0.000379	0.000562	CcSEcCtD
Posaconazole—Malnutrition—Doxorubicin—liver cancer	0.000378	0.00056	CcSEcCtD
Posaconazole—Erythema—Doxorubicin—liver cancer	0.000378	0.00056	CcSEcCtD
Posaconazole—Anaemia—Epirubicin—liver cancer	0.000378	0.00056	CcSEcCtD
Posaconazole—Agitation—Epirubicin—liver cancer	0.000375	0.000556	CcSEcCtD
Posaconazole—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I3—liver cancer	0.000374	0.0263	CbGpPWpGaD
Posaconazole—Flatulence—Doxorubicin—liver cancer	0.000372	0.000552	CcSEcCtD
Posaconazole—Dysgeusia—Doxorubicin—liver cancer	0.00037	0.000549	CcSEcCtD
Posaconazole—Malaise—Epirubicin—liver cancer	0.000368	0.000546	CcSEcCtD
Posaconazole—Vertigo—Epirubicin—liver cancer	0.000367	0.000544	CcSEcCtD
Posaconazole—ABCB1—Constitutive Androstane Receptor Pathway—NR1I3—liver cancer	0.000366	0.0257	CbGpPWpGaD
Posaconazole—Syncope—Epirubicin—liver cancer	0.000366	0.000543	CcSEcCtD
Posaconazole—Leukopenia—Epirubicin—liver cancer	0.000366	0.000542	CcSEcCtD
Posaconazole—Back pain—Doxorubicin—liver cancer	0.000366	0.000542	CcSEcCtD
Posaconazole—Muscle spasms—Doxorubicin—liver cancer	0.000363	0.000539	CcSEcCtD
Posaconazole—Loss of consciousness—Epirubicin—liver cancer	0.000359	0.000532	CcSEcCtD
Posaconazole—Cough—Epirubicin—liver cancer	0.000356	0.000528	CcSEcCtD
Posaconazole—Vision blurred—Doxorubicin—liver cancer	0.000356	0.000528	CcSEcCtD
Posaconazole—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1H4—liver cancer	0.000355	0.0249	CbGpPWpGaD
Posaconazole—Convulsion—Epirubicin—liver cancer	0.000354	0.000525	CcSEcCtD
Posaconazole—Hypertension—Epirubicin—liver cancer	0.000353	0.000523	CcSEcCtD
Posaconazole—Ill-defined disorder—Doxorubicin—liver cancer	0.000351	0.00052	CcSEcCtD
Posaconazole—Anaemia—Doxorubicin—liver cancer	0.000349	0.000518	CcSEcCtD
Posaconazole—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I3—liver cancer	0.000349	0.0245	CbGpPWpGaD
Posaconazole—CYP3A4—Farnesoid X Receptor  Pathway—NR1H4—liver cancer	0.000348	0.0245	CbGpPWpGaD
Posaconazole—Chest pain—Epirubicin—liver cancer	0.000348	0.000515	CcSEcCtD
Posaconazole—Arthralgia—Epirubicin—liver cancer	0.000348	0.000515	CcSEcCtD
Posaconazole—Myalgia—Epirubicin—liver cancer	0.000348	0.000515	CcSEcCtD
Posaconazole—Agitation—Doxorubicin—liver cancer	0.000347	0.000515	CcSEcCtD
Posaconazole—Anxiety—Epirubicin—liver cancer	0.000347	0.000514	CcSEcCtD
Posaconazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000345	0.000512	CcSEcCtD
Posaconazole—Discomfort—Epirubicin—liver cancer	0.000344	0.000509	CcSEcCtD
Posaconazole—Malaise—Doxorubicin—liver cancer	0.000341	0.000505	CcSEcCtD
Posaconazole—Dry mouth—Epirubicin—liver cancer	0.00034	0.000504	CcSEcCtD
Posaconazole—Vertigo—Doxorubicin—liver cancer	0.00034	0.000503	CcSEcCtD
Posaconazole—Syncope—Doxorubicin—liver cancer	0.000339	0.000502	CcSEcCtD
Posaconazole—Leukopenia—Doxorubicin—liver cancer	0.000338	0.000501	CcSEcCtD
Posaconazole—Confusional state—Epirubicin—liver cancer	0.000336	0.000498	CcSEcCtD
Posaconazole—Oedema—Epirubicin—liver cancer	0.000333	0.000494	CcSEcCtD
Posaconazole—Loss of consciousness—Doxorubicin—liver cancer	0.000332	0.000492	CcSEcCtD
Posaconazole—Infection—Epirubicin—liver cancer	0.000331	0.000491	CcSEcCtD
Posaconazole—Cough—Doxorubicin—liver cancer	0.00033	0.000489	CcSEcCtD
Posaconazole—Shock—Epirubicin—liver cancer	0.000328	0.000486	CcSEcCtD
Posaconazole—Convulsion—Doxorubicin—liver cancer	0.000327	0.000485	CcSEcCtD
Posaconazole—Nervous system disorder—Epirubicin—liver cancer	0.000327	0.000485	CcSEcCtD
Posaconazole—ABCB1—Constitutive Androstane Receptor Pathway—GSTA2—liver cancer	0.000327	0.0229	CbGpPWpGaD
Posaconazole—Thrombocytopenia—Epirubicin—liver cancer	0.000326	0.000484	CcSEcCtD
Posaconazole—Hypertension—Doxorubicin—liver cancer	0.000326	0.000484	CcSEcCtD
Posaconazole—Tachycardia—Epirubicin—liver cancer	0.000325	0.000482	CcSEcCtD
Posaconazole—Skin disorder—Epirubicin—liver cancer	0.000324	0.00048	CcSEcCtD
Posaconazole—Hyperhidrosis—Epirubicin—liver cancer	0.000322	0.000478	CcSEcCtD
Posaconazole—Arthralgia—Doxorubicin—liver cancer	0.000322	0.000477	CcSEcCtD
Posaconazole—Chest pain—Doxorubicin—liver cancer	0.000322	0.000477	CcSEcCtD
Posaconazole—Myalgia—Doxorubicin—liver cancer	0.000322	0.000477	CcSEcCtD
Posaconazole—Anxiety—Doxorubicin—liver cancer	0.000321	0.000475	CcSEcCtD
Posaconazole—CYP3A4—Aflatoxin B1 metabolism—GSTM1—liver cancer	0.00032	0.0224	CbGpPWpGaD
Posaconazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.00032	0.000474	CcSEcCtD
Posaconazole—Discomfort—Doxorubicin—liver cancer	0.000318	0.000471	CcSEcCtD
Posaconazole—Anorexia—Epirubicin—liver cancer	0.000318	0.000471	CcSEcCtD
Posaconazole—Dry mouth—Doxorubicin—liver cancer	0.000315	0.000466	CcSEcCtD
Posaconazole—Hypotension—Epirubicin—liver cancer	0.000311	0.000462	CcSEcCtD
Posaconazole—Confusional state—Doxorubicin—liver cancer	0.000311	0.000461	CcSEcCtD
Posaconazole—Oedema—Doxorubicin—liver cancer	0.000308	0.000457	CcSEcCtD
Posaconazole—CYP3A4—Estrogen metabolism—GSTA1—liver cancer	0.000308	0.0216	CbGpPWpGaD
Posaconazole—Infection—Doxorubicin—liver cancer	0.000306	0.000454	CcSEcCtD
Posaconazole—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000304	0.00045	CcSEcCtD
Posaconazole—Shock—Doxorubicin—liver cancer	0.000303	0.00045	CcSEcCtD
Posaconazole—Nervous system disorder—Doxorubicin—liver cancer	0.000302	0.000448	CcSEcCtD
Posaconazole—Thrombocytopenia—Doxorubicin—liver cancer	0.000302	0.000448	CcSEcCtD
Posaconazole—Insomnia—Epirubicin—liver cancer	0.000301	0.000447	CcSEcCtD
Posaconazole—Tachycardia—Doxorubicin—liver cancer	0.000301	0.000446	CcSEcCtD
Posaconazole—Skin disorder—Doxorubicin—liver cancer	0.0003	0.000444	CcSEcCtD
Posaconazole—Paraesthesia—Epirubicin—liver cancer	0.000299	0.000444	CcSEcCtD
Posaconazole—Hyperhidrosis—Doxorubicin—liver cancer	0.000298	0.000442	CcSEcCtD
Posaconazole—Dyspnoea—Epirubicin—liver cancer	0.000297	0.000441	CcSEcCtD
Posaconazole—Somnolence—Epirubicin—liver cancer	0.000296	0.000439	CcSEcCtD
Posaconazole—Anorexia—Doxorubicin—liver cancer	0.000294	0.000436	CcSEcCtD
Posaconazole—Dyspepsia—Epirubicin—liver cancer	0.000293	0.000435	CcSEcCtD
Posaconazole—Decreased appetite—Epirubicin—liver cancer	0.00029	0.00043	CcSEcCtD
Posaconazole—Hypotension—Doxorubicin—liver cancer	0.000288	0.000427	CcSEcCtD
Posaconazole—Gastrointestinal disorder—Epirubicin—liver cancer	0.000288	0.000427	CcSEcCtD
Posaconazole—Fatigue—Epirubicin—liver cancer	0.000287	0.000426	CcSEcCtD
Posaconazole—Constipation—Epirubicin—liver cancer	0.000285	0.000423	CcSEcCtD
Posaconazole—Pain—Epirubicin—liver cancer	0.000285	0.000423	CcSEcCtD
Posaconazole—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000281	0.000417	CcSEcCtD
Posaconazole—Insomnia—Doxorubicin—liver cancer	0.000279	0.000414	CcSEcCtD
Posaconazole—Paraesthesia—Doxorubicin—liver cancer	0.000277	0.000411	CcSEcCtD
Posaconazole—Dyspnoea—Doxorubicin—liver cancer	0.000275	0.000408	CcSEcCtD
Posaconazole—Feeling abnormal—Epirubicin—liver cancer	0.000275	0.000407	CcSEcCtD
Posaconazole—Somnolence—Doxorubicin—liver cancer	0.000274	0.000406	CcSEcCtD
Posaconazole—Gastrointestinal pain—Epirubicin—liver cancer	0.000273	0.000404	CcSEcCtD
Posaconazole—Dyspepsia—Doxorubicin—liver cancer	0.000272	0.000402	CcSEcCtD
Posaconazole—Decreased appetite—Doxorubicin—liver cancer	0.000268	0.000397	CcSEcCtD
Posaconazole—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000266	0.000395	CcSEcCtD
Posaconazole—Fatigue—Doxorubicin—liver cancer	0.000266	0.000394	CcSEcCtD
Posaconazole—Urticaria—Epirubicin—liver cancer	0.000265	0.000393	CcSEcCtD
Posaconazole—Pain—Doxorubicin—liver cancer	0.000264	0.000391	CcSEcCtD
Posaconazole—Constipation—Doxorubicin—liver cancer	0.000264	0.000391	CcSEcCtD
Posaconazole—Abdominal pain—Epirubicin—liver cancer	0.000264	0.000391	CcSEcCtD
Posaconazole—Body temperature increased—Epirubicin—liver cancer	0.000264	0.000391	CcSEcCtD
Posaconazole—Feeling abnormal—Doxorubicin—liver cancer	0.000254	0.000377	CcSEcCtD
Posaconazole—Gastrointestinal pain—Doxorubicin—liver cancer	0.000252	0.000374	CcSEcCtD
Posaconazole—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—liver cancer	0.000248	0.0174	CbGpPWpGaD
Posaconazole—Hypersensitivity—Epirubicin—liver cancer	0.000246	0.000364	CcSEcCtD
Posaconazole—Urticaria—Doxorubicin—liver cancer	0.000245	0.000363	CcSEcCtD
Posaconazole—Body temperature increased—Doxorubicin—liver cancer	0.000244	0.000361	CcSEcCtD
Posaconazole—Abdominal pain—Doxorubicin—liver cancer	0.000244	0.000361	CcSEcCtD
Posaconazole—Asthenia—Epirubicin—liver cancer	0.000239	0.000355	CcSEcCtD
Posaconazole—Pruritus—Epirubicin—liver cancer	0.000236	0.00035	CcSEcCtD
Posaconazole—Diarrhoea—Epirubicin—liver cancer	0.000228	0.000338	CcSEcCtD
Posaconazole—Hypersensitivity—Doxorubicin—liver cancer	0.000227	0.000337	CcSEcCtD
Posaconazole—CYP3A4—Constitutive Androstane Receptor Pathway—NR1I3—liver cancer	0.000226	0.0158	CbGpPWpGaD
Posaconazole—Asthenia—Doxorubicin—liver cancer	0.000221	0.000328	CcSEcCtD
Posaconazole—Dizziness—Epirubicin—liver cancer	0.00022	0.000327	CcSEcCtD
Posaconazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1H4—liver cancer	0.000219	0.0154	CbGpPWpGaD
Posaconazole—Pruritus—Doxorubicin—liver cancer	0.000218	0.000323	CcSEcCtD
Posaconazole—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—liver cancer	0.000218	0.0153	CbGpPWpGaD
Posaconazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I3—liver cancer	0.000215	0.0151	CbGpPWpGaD
Posaconazole—Vomiting—Epirubicin—liver cancer	0.000212	0.000314	CcSEcCtD
Posaconazole—Diarrhoea—Doxorubicin—liver cancer	0.000211	0.000313	CcSEcCtD
Posaconazole—Rash—Epirubicin—liver cancer	0.00021	0.000312	CcSEcCtD
Posaconazole—Dermatitis—Epirubicin—liver cancer	0.00021	0.000311	CcSEcCtD
Posaconazole—Headache—Epirubicin—liver cancer	0.000209	0.00031	CcSEcCtD
Posaconazole—ABCB1—HIF-1-alpha transcription factor network—NDRG1—liver cancer	0.000205	0.0144	CbGpPWpGaD
Posaconazole—Dizziness—Doxorubicin—liver cancer	0.000204	0.000302	CcSEcCtD
Posaconazole—CYP3A4—Constitutive Androstane Receptor Pathway—GSTA2—liver cancer	0.000201	0.0141	CbGpPWpGaD
Posaconazole—Nausea—Epirubicin—liver cancer	0.000198	0.000294	CcSEcCtD
Posaconazole—Vomiting—Doxorubicin—liver cancer	0.000196	0.000291	CcSEcCtD
Posaconazole—Rash—Doxorubicin—liver cancer	0.000194	0.000288	CcSEcCtD
Posaconazole—Dermatitis—Doxorubicin—liver cancer	0.000194	0.000288	CcSEcCtD
Posaconazole—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—liver cancer	0.000193	0.0136	CbGpPWpGaD
Posaconazole—Headache—Doxorubicin—liver cancer	0.000193	0.000286	CcSEcCtD
Posaconazole—Nausea—Doxorubicin—liver cancer	0.000183	0.000272	CcSEcCtD
Posaconazole—CYP3A4—Xenobiotics—CYP2E1—liver cancer	0.000182	0.0128	CbGpPWpGaD
Posaconazole—CYP3A4—Tamoxifen metabolism—CYP2E1—liver cancer	0.000175	0.0123	CbGpPWpGaD
Posaconazole—CYP3A4—Aflatoxin activation and detoxification—GGT1—liver cancer	0.000174	0.0122	CbGpPWpGaD
Posaconazole—ABCB1—Allograft Rejection—IL12A—liver cancer	0.000163	0.0114	CbGpPWpGaD
Posaconazole—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—liver cancer	0.000156	0.011	CbGpPWpGaD
Posaconazole—CYP3A4—Estrogen metabolism—GSTM1—liver cancer	0.00015	0.0105	CbGpPWpGaD
Posaconazole—CYP3A4—Estrogen metabolism—CYP1A1—liver cancer	0.000142	0.01	CbGpPWpGaD
Posaconazole—ABCB1—HIF-1-alpha transcription factor network—HNF4A—liver cancer	0.000142	0.00999	CbGpPWpGaD
Posaconazole—CYP3A4—Cytochrome P450 - arranged by substrate type—NR1H4—liver cancer	0.000139	0.00975	CbGpPWpGaD
Posaconazole—CYP3A4—Irinotecan Pathway—APC—liver cancer	0.000136	0.00957	CbGpPWpGaD
Posaconazole—CYP3A4—Xenobiotics—CYP1A1—liver cancer	0.000131	0.00919	CbGpPWpGaD
Posaconazole—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—liver cancer	0.000127	0.00892	CbGpPWpGaD
Posaconazole—CYP3A4—Tamoxifen metabolism—CYP1A1—liver cancer	0.000126	0.00884	CbGpPWpGaD
Posaconazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—liver cancer	0.000119	0.00837	CbGpPWpGaD
Posaconazole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABL1—liver cancer	0.000116	0.00817	CbGpPWpGaD
Posaconazole—CYP3A4—Phase 1 - Functionalization of compounds—NR1H4—liver cancer	0.000113	0.0079	CbGpPWpGaD
Posaconazole—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—liver cancer	0.000105	0.00737	CbGpPWpGaD
Posaconazole—CYP3A4—Biological oxidations—UGDH—liver cancer	0.000102	0.00719	CbGpPWpGaD
Posaconazole—ABCB1—Allograft Rejection—IL12B—liver cancer	0.000102	0.00717	CbGpPWpGaD
Posaconazole—CYP3A4—Tryptophan metabolism—CYP2E1—liver cancer	9.36e-05	0.00657	CbGpPWpGaD
Posaconazole—ABCB1—HIF-1-alpha transcription factor network—HMOX1—liver cancer	9.25e-05	0.0065	CbGpPWpGaD
Posaconazole—ABCB1—Transmembrane transport of small molecules—MYO5B—liver cancer	8e-05	0.00562	CbGpPWpGaD
Posaconazole—ABCB1—Transmembrane transport of small molecules—SLC9C1—liver cancer	8e-05	0.00562	CbGpPWpGaD
Posaconazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—liver cancer	7.83e-05	0.0055	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—FST—liver cancer	7.82e-05	0.00549	CbGpPWpGaD
Posaconazole—ABCB1—HIF-1-alpha transcription factor network—TERT—liver cancer	7.6e-05	0.00533	CbGpPWpGaD
Posaconazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—liver cancer	7.56e-05	0.00531	CbGpPWpGaD
Posaconazole—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—liver cancer	7.46e-05	0.00524	CbGpPWpGaD
Posaconazole—CYP3A4—Tryptophan metabolism—CYP1A1—liver cancer	6.72e-05	0.00472	CbGpPWpGaD
Posaconazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—liver cancer	6.47e-05	0.00454	CbGpPWpGaD
Posaconazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	6.13e-05	0.00431	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—liver cancer	6.08e-05	0.00427	CbGpPWpGaD
Posaconazole—CYP3A4—Biological oxidations—NR1H4—liver cancer	5.98e-05	0.0042	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—liver cancer	5.96e-05	0.00419	CbGpPWpGaD
Posaconazole—CYP3A4—Biological oxidations—GSTA3—liver cancer	5.88e-05	0.00413	CbGpPWpGaD
Posaconazole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—liver cancer	5.84e-05	0.0041	CbGpPWpGaD
Posaconazole—CYP3A4—Metapathway biotransformation—GSTA3—liver cancer	5.8e-05	0.00407	CbGpPWpGaD
Posaconazole—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—liver cancer	5.57e-05	0.00391	CbGpPWpGaD
Posaconazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	5.43e-05	0.00382	CbGpPWpGaD
Posaconazole—CYP3A4—Biological oxidations—GSTA4—liver cancer	5.38e-05	0.00377	CbGpPWpGaD
Posaconazole—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—liver cancer	5.36e-05	0.00377	CbGpPWpGaD
Posaconazole—CYP3A4—Metapathway biotransformation—GSTA4—liver cancer	5.3e-05	0.00372	CbGpPWpGaD
Posaconazole—CYP3A4—Biological oxidations—GSTA2—liver cancer	5.24e-05	0.00368	CbGpPWpGaD
Posaconazole—CYP3A4—Biological oxidations—GSTA1—liver cancer	5.05e-05	0.00355	CbGpPWpGaD
Posaconazole—CYP3A4—Biological oxidations—NAT2—liver cancer	5e-05	0.00351	CbGpPWpGaD
Posaconazole—CYP3A4—Metapathway biotransformation—NAT2—liver cancer	4.93e-05	0.00346	CbGpPWpGaD
Posaconazole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—liver cancer	4.47e-05	0.00314	CbGpPWpGaD
Posaconazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	4.41e-05	0.00309	CbGpPWpGaD
Posaconazole—ABCB1—HIF-1-alpha transcription factor network—JUN—liver cancer	4.38e-05	0.00308	CbGpPWpGaD
Posaconazole—CYP3A4—Metapathway biotransformation—GPX3—liver cancer	4.19e-05	0.00294	CbGpPWpGaD
Posaconazole—ABCB1—Transmembrane transport of small molecules—SLC11A2—liver cancer	4.1e-05	0.00288	CbGpPWpGaD
Posaconazole—CYP3A4—Biological oxidations—HPGDS—liver cancer	4e-05	0.00281	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—liver cancer	3.92e-05	0.00275	CbGpPWpGaD
Posaconazole—ABCB1—Transmembrane transport of small molecules—SLC40A1—liver cancer	3.91e-05	0.00274	CbGpPWpGaD
Posaconazole—ABCB1—Allograft Rejection—CASP3—liver cancer	3.91e-05	0.00274	CbGpPWpGaD
Posaconazole—ABCB1—Allograft Rejection—IL2—liver cancer	3.9e-05	0.00274	CbGpPWpGaD
Posaconazole—ABCB1—HIF-1-alpha transcription factor network—VEGFA—liver cancer	3.83e-05	0.00269	CbGpPWpGaD
Posaconazole—ABCB1—Transmembrane transport of small molecules—ANXA2—liver cancer	3.75e-05	0.00263	CbGpPWpGaD
Posaconazole—ABCB1—Transmembrane transport of small molecules—ATP7B—liver cancer	3.75e-05	0.00263	CbGpPWpGaD
Posaconazole—ABCB1—Transmembrane transport of small molecules—NR1H4—liver cancer	3.54e-05	0.00249	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—liver cancer	3.36e-05	0.00236	CbGpPWpGaD
Posaconazole—ABCB1—Allograft Rejection—VEGFA—liver cancer	3.32e-05	0.00233	CbGpPWpGaD
Posaconazole—CYP3A4—Biological oxidations—CYP2E1—liver cancer	3.26e-05	0.00229	CbGpPWpGaD
Posaconazole—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	3.21e-05	0.00226	CbGpPWpGaD
Posaconazole—ABCB1—Allograft Rejection—TGFB1—liver cancer	3.04e-05	0.00214	CbGpPWpGaD
Posaconazole—CYP3A4—Biological oxidations—GGT1—liver cancer	2.99e-05	0.0021	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK14—liver cancer	2.95e-05	0.00207	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—liver cancer	2.89e-05	0.00203	CbGpPWpGaD
Posaconazole—ABCB1—Allograft Rejection—TNF—liver cancer	2.84e-05	0.002	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—UGDH—liver cancer	2.84e-05	0.00199	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—APC—liver cancer	2.74e-05	0.00192	CbGpPWpGaD
Posaconazole—CYP3A4—Biological oxidations—GSTP1—liver cancer	2.69e-05	0.00189	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—EPT1—liver cancer	2.67e-05	0.00188	CbGpPWpGaD
Posaconazole—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	2.65e-05	0.00186	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—TAT—liver cancer	2.53e-05	0.00178	CbGpPWpGaD
Posaconazole—CYP3A4—Biological oxidations—GSTM1—liver cancer	2.47e-05	0.00173	CbGpPWpGaD
Posaconazole—ABCB1—HIF-1-alpha transcription factor network—AKT1—liver cancer	2.44e-05	0.00172	CbGpPWpGaD
Posaconazole—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	2.43e-05	0.00171	CbGpPWpGaD
Posaconazole—CYP3A4—Biological oxidations—CYP1A1—liver cancer	2.34e-05	0.00164	CbGpPWpGaD
Posaconazole—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	2.31e-05	0.00162	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—liver cancer	2.15e-05	0.00151	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—liver cancer	1.97e-05	0.00138	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—liver cancer	1.93e-05	0.00135	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—liver cancer	1.88e-05	0.00132	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—liver cancer	1.87e-05	0.00132	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—liver cancer	1.86e-05	0.00131	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—liver cancer	1.82e-05	0.00127	CbGpPWpGaD
Posaconazole—ABCB1—Transmembrane transport of small molecules—CYCS—liver cancer	1.81e-05	0.00127	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—liver cancer	1.77e-05	0.00124	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—UGDH—liver cancer	1.75e-05	0.00123	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—GLUL—liver cancer	1.72e-05	0.00121	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—CPT1B—liver cancer	1.72e-05	0.00121	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—NR1H4—liver cancer	1.66e-05	0.00117	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—EPT1—liver cancer	1.65e-05	0.00116	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	1.64e-05	0.00115	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—GSTA3—liver cancer	1.63e-05	0.00115	CbGpPWpGaD
Posaconazole—ABCB1—Transmembrane transport of small molecules—HMOX1—liver cancer	1.57e-05	0.0011	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—TAT—liver cancer	1.56e-05	0.0011	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	1.51e-05	0.00106	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	1.5e-05	0.00105	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—GSTA4—liver cancer	1.49e-05	0.00105	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—GSTA2—liver cancer	1.45e-05	0.00102	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—GSTA1—liver cancer	1.4e-05	0.000985	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	1.4e-05	0.000985	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	1.39e-05	0.000977	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—NAT2—liver cancer	1.39e-05	0.000974	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—ALDOB—liver cancer	1.33e-05	0.000934	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	1.28e-05	0.000897	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—CRABP1—liver cancer	1.27e-05	0.000891	CbGpPWpGaD
Posaconazole—ABCB1—Transmembrane transport of small molecules—PPARA—liver cancer	1.27e-05	0.000891	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	1.24e-05	0.000868	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—HPGDS—liver cancer	1.11e-05	0.000779	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—CPT1B—liver cancer	1.06e-05	0.000745	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—GLUL—liver cancer	1.06e-05	0.000745	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	1.04e-05	0.000733	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—NR1H4—liver cancer	1.02e-05	0.000718	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—GSTA3—liver cancer	1.01e-05	0.000706	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—PSMD10—liver cancer	9.89e-06	0.000694	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—PSMA4—liver cancer	9.89e-06	0.000694	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—GOT2—liver cancer	9.62e-06	0.000675	CbGpPWpGaD
Posaconazole—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	9.43e-06	0.000662	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—GSTA4—liver cancer	9.19e-06	0.000646	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—CYP2E1—liver cancer	9.04e-06	0.000635	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—GSTA2—liver cancer	8.96e-06	0.000629	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—GSTA1—liver cancer	8.64e-06	0.000607	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—NAT2—liver cancer	8.55e-06	0.0006	CbGpPWpGaD
Posaconazole—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	8.53e-06	0.000599	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—CYCS—liver cancer	8.46e-06	0.000594	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—GOT1—liver cancer	8.3e-06	0.000583	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—GGT1—liver cancer	8.3e-06	0.000583	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—ALDOB—liver cancer	8.2e-06	0.000575	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—CRABP1—liver cancer	7.82e-06	0.000549	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—GSTP1—liver cancer	7.46e-06	0.000524	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—HMOX1—liver cancer	7.35e-06	0.000516	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—GSTM1—liver cancer	6.85e-06	0.000481	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—HPGDS—liver cancer	6.83e-06	0.00048	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—CYP1A1—liver cancer	6.5e-06	0.000456	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—PSMD10—liver cancer	6.09e-06	0.000428	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—PSMA4—liver cancer	6.09e-06	0.000428	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—MTHFR—liver cancer	6.06e-06	0.000425	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—PPARA—liver cancer	5.94e-06	0.000417	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—GOT2—liver cancer	5.92e-06	0.000416	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—CYP2E1—liver cancer	5.57e-06	0.000391	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—CYCS—liver cancer	5.21e-06	0.000366	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—GGT1—liver cancer	5.11e-06	0.000359	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—GOT1—liver cancer	5.11e-06	0.000359	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—PIK3CG—liver cancer	5.09e-06	0.000357	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—PPARG—liver cancer	4.91e-06	0.000345	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—GSTP1—liver cancer	4.59e-06	0.000323	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—HMOX1—liver cancer	4.53e-06	0.000318	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—PIK3CD—liver cancer	4.47e-06	0.000314	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—ALB—liver cancer	4.42e-06	0.00031	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—GSTM1—liver cancer	4.22e-06	0.000296	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—CYP1A1—liver cancer	4e-06	0.000281	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—PIK3CB—liver cancer	3.9e-06	0.000274	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—MTHFR—liver cancer	3.73e-06	0.000262	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—PPARA—liver cancer	3.66e-06	0.000257	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—PIK3CG—liver cancer	3.13e-06	0.00022	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—PPARG—liver cancer	3.03e-06	0.000212	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—PIK3CD—liver cancer	2.76e-06	0.000193	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—ALB—liver cancer	2.72e-06	0.000191	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—PIK3CB—liver cancer	2.4e-06	0.000169	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—PIK3CA—liver cancer	2.38e-06	0.000167	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—AKT1—liver cancer	1.94e-06	0.000136	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—PIK3CA—liver cancer	1.46e-06	0.000103	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—AKT1—liver cancer	1.2e-06	8.4e-05	CbGpPWpGaD
